Effects of a Multimodal Physical Exercise and Functional Rehabilitation Program on Fatigue, Pain, Functional Capacity and Quality of Life in Cancer Patients With Tumor Asthenia.

Effects of a Multimodal Physical Exercise and Functional Rehabilitation Program on Fatigue, Pain, Functional Capacity and Quality of Life in Cancer Patients With Tumor Asthenia. Controlled Clinical Trial.

Tumor asthenia is the most common symptom associated with cancer and its treatment. Although the estimated prevalence varies between 60-90%, and it is considered the longest-lasting symptom in cancer patients, having the greatest impact on quality of life parameters, it is a problem that is still undervalued in general by health professionals . It has been observed that individuals with this process find it difficult to normalize their daily life, either due to a deterioration in their clinical condition or due to a problem in the generalization of what they have learned during their hospital stay. That is why we plan to carry out a clinical trial, to evaluate the effect of a controlled patient follow-up program, and thus be able to address these difficulties in the most optimal way. A randomized clinical trial of two parallel groups will be carried out, belonging to the oncology service of the University Hospital of Salamanca. 44 participants with tumor asthenia, who are admitted at the time of inclusion, will be selected through a consecutive sampling. After the baseline evaluation, the participants will be randomized into two groups. The subjects of the experimental group will carry out a Functional Rehabilitation Program, with a duration of one month. The main variable will be the evaluation of the basic activities of daily life (Barthel scale). The secondary variables will be oriented to evaluate the change in tumor asthenia, attention and cognitive functions, parameters of quality of life, pain, functional capacity and body composition. The results of this study could be transferred to the clinic, incorporating them into care protocols for cancer patients with tumor asthenia.

Inclusion criteria:

• Having among the reasons for admission a pathological diagnosis of newly diagnosed or relapsed oncological disease.
• Being admitted to the Oncology Service of the Salamanca University Hospital.
• Barthel index score between 15 and 55 points.
• Level of tumor asthenia greater than or equal to 4 on the EVA scale for tumor asthenia.
• Sign an informed consent in which they authorize their voluntary participation in the study (Annex II).

Exclusion criteria:

• Present cognitive impairment assessed with the Mini-mental State Examination (MMSE) less than 24 points.
• Present hemoglobin levels below 10g / dl.

Withdrawal criteria:

• Exitus of the patient.
• Progression of the disease leading to a terminal state.
• Hospitalization of the patient at the time of home monitoring.
• Do not carry out Final Assessment.